Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Hematologic

Scinnohub Pharmaceutical identifies new plasmin inhibitors

Aug. 30, 2022

Scinnohub Pharmaceutical Co. Ltd. has presented plasmin inhibitors reported to be useful for the treatment of hemorrhage.

SBIR grant supports STRM.BIO's development of EV technology as gene therapy delivery platform

July 27, 2022

ScinnoHub Pharmaceutical discovers plasmin inhibitors

July 27, 2022

Biallelic variants in RASGRP2 gene tied to bleeding diathesis

July 21, 2022

Fgg-impaired zebrafish present dysfibrinogenemia

July 19, 2022

Thrombogenic effects of allosteric SHP2 inhibitor SHP-099

July 18, 2022

Murine model shows fibrin alpha crosslinking impairment behind thromboembolism

July 18, 2022

PCYOX1 identified as new target for antithrombotic therapy

July 18, 2022

Coagulant Therapeutics presents preclinical data on CT-001

July 18, 2022

Novel hemophilia A murine model to test IdeS proteinase efficacy

July 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...